Our aim was to compare patients' satisfaction and cooperation, and clinical efficacy, of
midazolam alone, and midazolam and remifentanil for patient-controlled sedation during
removal of third molars. Forty patients, American Society of Anesthesiologists grades I and II,
admitted for extraction of impacted mandibular third molars were included in this
randomised, prospective study. They were given an intravenous bolus of midazolam 0.03
mg/kg and then allowed to use patient-controlled sedation. In the midazolam group, 2ml of …